Cart
sales@molnova.com
Neuropeptide Y (13-36) (porcine)
CAS No. 113662-54-7
Neuropeptide Y (13-36) (porcine)( ——— )
Catalog No. M40290 CAS No. 113662-54-7
Neuropeptide Y (13-36), porcine is a selective neuropeptide Y2 receptor agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 500 | In Stock |
|
| 10MG | 786 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNeuropeptide Y (13-36) (porcine)
-
NoteResearch use only, not for human use.
-
Brief DescriptionNeuropeptide Y (13-36), porcine is a selective neuropeptide Y2 receptor agonist.
-
DescriptionNeuropeptide Y (13-36), porcine is a selective neuropeptide Y2 receptor agonist.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number113662-54-7
-
Formula Weight2982.408
-
Molecular FormulaC135H209N41O36
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL (16.77 mM; ultraphonic; ) H2O : ≥ 50 mg/mL (16.77 mM)
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Aguirre JA, et al. Centrally injected neuropeptide Y (13-36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1-36) in the awake male rat. Neurosci Lett. 1990 Oct 2;118(1):5-8.?
molnova catalog
related products
-
6-Epiagarotetrol
6-Epiagarotetrol is a neuroprotective agent can be extracted from Aquilaria sinensis. 6-Epiagarotetrol has a protective effect on corticosterone-induced PC12 cell damage.
-
Ac-IEVDIDVE (TFA)
Ac-IEVDIDVE TFA is a short peptide sequence.
-
Endotoxin Inhibitor
Endotoxin inhibitor a synthetic peptide that binds lipid A with high affinity, thereby detoxifying LPS and preventing LPS-induced cytokine release in vivo. Endotoxin inhibitor inhibits the febrile response to LPS with very low toxicity and lethality.
